Elon Musk's Tesla signs €14 billion chip deal with Samsung Electronics
'Samsung's giant new Texas fab will be dedicated to making Tesla's next-generation AI6 chip. The strategic importance of this is hard to overstate,' Musk said.
The deal is a major win for the South Korean tech giant, which lost major clients like Google in recent years to competitors such as the Taiwan Semiconductor Manufacturing Company (TSMC) due to workflow issues and low production yields.
'Samsung agreed to allow Tesla to assist in maximizing manufacturing efficiency,' Musk continued in the post. 'This is a critical point, as I will walk the line personally to accelerate the pace of progress.'
While Samsung already produces the AI4 and has been working with Tesla since 2017, it lost the AI5 deal to TSMC, who initially produced it in Taiwan and will soon be moving production to a plant in Arizona.
According to another post on X, the deal amounts to $16.5 billion (€14 billion), which Musk claims is "just the bare minimum. Actual output is likely to be several times higher".
Besides Tesla vehicles, the upcoming AI6 chip is expected to power the technological advancement of Tesla's humanoid robots and will be involved in AI model training.
What's so 'fab' about the new fab?
A fab is a tech industry term for a semiconductor fabrication plant or a cutting-edge factory where companies like Tesla get their custom computer chips built after they are designed.
There are only a few tech giants in the world that have the excruciatingly precise machinery to build 2-nanometer (nm) chips, which fit 50 billion transistors on a chip barely the size of a human fingernail.
The obsession with miniaturization in the tech world is part of a drive to achieve better computational power and combine it with greater energy efficiency.
The South Korean multinational conglomerate has been operating a semiconductor plant in Austin, Texas, since 1996. However, the new AI6 Tesla chip will be produced in a new plant in Taylor, around 50 kilometres away from the original fab.
'The fab is conveniently located not far from my house,' Musk said in the post.
Musk has lived near the launch site of his space exploration company, SpaceX, in Texas since 2021.
The Samsung deal is in line with the Chips and Science Act, a US bill passed in 2022, which aims to bring more of the highly profitable semiconductor manufacturing industry to the US, instead of relying on overseas producers.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Euronews
4 hours ago
- Euronews
Doctors vs AI: Who wins in the battle of medical diagnosis?
A face-off between humans and machines drew crowds at the World AI Conference in Shanghai, where radiologists went head-to-head with artificial intelligence in a live competition. The AI-Human Synergy Competition featured six top radiologists from Zhongshan Hospital, split into two teams: the 'AI Collaboration Group" that had a helping hand from an AI system, and the 'Manual Group' which relied solely on their personal expertise. Both teams were presented with the same chest x-ray cases and asked to analyse and report their findings live. Who won the showdown: Doctors or AI? Although the AI-assisted team worked faster, they missed some important diagnoses, and the human team was able to identify conditions the AI group missed. According to experts, the human report was also more readable, with a warmer tone and better overall structure. "I noticed our senior physicians carefully adjusted the structure of the report," said Wang Yi, director of the radiology department at Peking University People's Hospital. "They made it into a coherent report with clear internal logic, unlike the AI-generated version where each item was listed separately". "In terms of time, AI is definitely faster. Accuracy is roughly comparable, but I have to say the manual group feels warmer and more empathetic," said Zeng Mengsu, director of radiology and chief of diagnostic radiology at Zhongshan Hospital. "Both cases involved 'annual follow-ups,' yet the doctor group without AI assistance also provided personalised recommendations – such as follow-up ultrasounds or revisits within 6 to 12 months," Mengsu added. Is this the future of medical diagnostics? The technology used in the showdown was the 'One-Scan-for-All' chest system, co-developed by Zhongshan Hospital and Shanghai United Imaging Medical Technology. Unlike conventional models that focus on detecting a single disease, this system is currently capable of identifying 73 common thoracic abnormalities in one scan, from pulmonary nodules and emphysema to fractures and coronary artery calcifications. "Its current accuracy rate is around 85 per cent, and we aim to raise that to 95 per cent in the future – I'm confident we'll get there," Zeng explained the event. "Ultimately, we hope to double the work efficiency of radiologists through this technology". The team behind the AI also has broader ambitions beyond just focusing exclusively on lung-related issues. Zhou Xiang, co-founder and co-CEO of United Imaging Intelligence, said the group is working on a brain MRI programme with the goal of having one scan for multiple health issues. "So far, we've covered over 30 diseases and are now expanding into orthopedics, ultrasound, and abdominal imaging," Xiang said. The showdown in Shanghai comes amid a wave of breakthroughs in AI medical diagnostics. Microsoft recently announced that its latest AI tool outperformed doctors in a study involving complex medical cases. Tested against 21 experienced physicians from the United Kingdom and United States, the system correctly diagnosed up to 85.5 per cent of patient cases - roughly four times more than the group of doctors. The model was also cheaper than human doctors, ordering fewer scans and tests to reach the correct diagnosis, the analysis found. While the company isn't suggesting AI will replace doctors, it believes these systems could dramatically improve speed, accuracy, and personalisation in health care.
France 24
15 hours ago
- France 24
Palantir, the AI giant that preaches US dominance
The company's reach spans the global economy, with banks, hospitals, the US government, and the Israeli military among its ever-expanding client roster. "We want and need this country to be the strongest, most important country in the world," Alex Karp, Palantir's CEO, recently declared at a client conference in Palo Alto, California, where AFP was the only media outlet present. In armed conflicts -- most notably in Ukraine -- Palantir's tools help evaluate potential targets in real-time, using multiple sources, including biometric data and intercepted phone calls. "I'm super proud of... what we do to protect our soldiers... (using our AI) to kill our enemies and scare them, because they know they will be killed," the graying, curly-haired billionaire continued, wearing a tight white T-shirt. Washington has been filling Palantir's coffers. In the first quarter, the company received $373 million from the US government -- a 45 percent jump from the previous year -- and it's not all miltary spending. This spring, federal immigration authorities (ICE) awarded the company a $30 million contract to develop a new platform for tracking deportations and visa overstays. 'Like a drug' The company then secured an investment of nearly $800 million from the US military, adding to the $480 million contract signed in May 2024 for its AI platform supporting the Pentagon's "Project Maven" target identification program. This marked Palantir's first billion-dollar contract, elevating it alongside government contracting stalwarts like Microsoft and Amazon's AWS. However, financial results "are not and will never be the ultimate measure of the value, broadly defined, of our business," Karp wrote in his letter to shareholders in early May, where he tossed in quotes from Saint Augustine, the Bible and Richard Nixon. "We have grander and more idiosyncratic aims." Palantir was founded in 2003 by Peter Thiel -- Silicon Valley's preeminent conservative -- Karp, and others with CIA backing. The company takes its name from the magical seeing stones in Tolkien's "Lord of the Rings." "Young people would say we're like pure drugs -- very expensive, highly sought after... that make you stronger and better," Karp boasted on stage. Palantir's expanding footprint at the highest levels of government has raised eyebrows. Several members of the Trump administration's "DOGE" cost-cutting commission, originally headed by Elon Musk, came from the company. Recent reports from The New York Times, Wired, and CNN have detailed secret government projects to create, with Palantir's help, a central database combining data from different federal agencies. 'Deeply proud' This development has created "a lot of concerns about how that information might be used," warned Elizabeth Laird from the Center for Democracy & Technology. Palantir maintains it isn't building "surveillance technology" or a "central database on Americans." Unlike most traditional Silicon Valley companies that have kept military projects discreet, Palantir now embraces its defense work openly. Sasha Spivak, director of strategy, said that when she joined Palantir ten years ago, the company kept its sense of purpose behind closed doors. "Today we're not ashamed, we're not afraid, and we're deeply proud of what we do and our clients," said Spivak. Some employee groups are pushing back. In early May, 13 former Palantir employees published a letter accusing tech giants of helping to "normalize authoritarianism under the cover of a 'revolution' led by oligarchs." They argue that by supporting the Trump administration and DOGE, Palantir has betrayed its stated values of ethics, transparency, and defending democracy. "When I joined the company... there were many smart, motivated people -- that's pretty rare," said one of the letter's signatories, who wishes to remain anonymous, for fear of reprisal. After months of seeking management explanations about Palantir's collaboration with Israel and ICE, several of these employees resigned. "They said, 'We're a company that's very responsive to employees,' but people asking about Israel were quickly shut down and told, 'That's what we do -- if you don't like it, you can leave,'" the former staffer recalled. Jeremy David, co-director of the Health division, plays down the controversies. "My daily life is more about nurses and doctors who often hate us at first and are very grateful at the end," he told AFP at the conference. On stage, Joe Bonanno, head of data analysis at Citibank, celebrated how one operation that previously required "nine days and sometimes 50 people" now "takes just a few minutes for one person." "Like I said, and like Alex said, I came to dominate, crush and annihilate. So if you're JPMorgan, Merrill Lynch, Morgan Stanley, sorry," he concluded with a broad smile.
France 24
a day ago
- France 24
AI Ray-Ban Meta glasses help EssilorLuxottica boost sales
The group's revenue climbed by 5.5 percent to 14 billion euros ($16.2 billion) in the first half of the year, with net profit edging 1.6 percent higher to 1.4 billion euros. EssilorLuxottica's chief executive Francesco Milleri said results showed the group is "keeping pace with our growth targets despite a volatile environment". Like other European companies, the weak dollar impacted the company's performance in the North American region, nearly wiping out growth in the second quarter. EssilorLuxottica said AI glasses gained momentum in the first half of the year, with Ray-Ban Meta more than tripling in revenue year-over-year. It also announced new AI-enabled Oakley glasses in June. "We are leading the transformation of glasses as the next computing platform, one where AI, sensory tech and a data-rich healthcare infrastructure will converge to empower humans and unlock our full potential," said Milleri. The Ray-Ban glasses, equipped with camera, headphones and microphones, allow wearers to prompt Meta's AI without opening their phone by saying "Hey Meta". The company did not provide sales figures for the glasses or comment on the minority stake Meta has taken in it, which was disclosed earlier this month by Bloomberg. The company is a leading manufacturer of corrective lenses as well as frames, having acquired the rights to manufacture eyewear for numerous luxury brands including Giorgio Armani, Burberry, Chanel, Dolce&Gabbana, Prada and Versace.
